RecruitingPhase 1NCT06533332

A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors

Studying Malignant epithelial tumor of ovary

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
EtiraRx Australia Pty Ltd
Principal Investigator
Rasha Cosman, MBBS
The Kinghorn Cancer Centre
Intervention
ERX-315(drug)
Enrollment
15 enrolled
Eligibility
18 years · All sexes
Timeline
20242026

Study locations (4)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06533332 on ClinicalTrials.gov

Other trials for Malignant epithelial tumor of ovary

Additional recruiting or active studies for the same condition.

See all trials for Malignant epithelial tumor of ovary

← Back to all trials